Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases

被引：68

作者：

Claridge, Stephen ^{[1
]}

Raeppel, Franck ^{[1
]}

Granger, Marie-Claude ^{[1
]}

Bernstein, Naomy ^{[1
]}

Saavedra, Oscar ^{[1
]}

Zhan, Lijie ^{[1
]}

Llewellyn, David ^{[1
]}

Wahhab, Amal ^{[1
]}

Deziel, Robert ^{[1
]}

Rahil, Jubrail ^{[3
]}

Beaulieu, Normand ^{[2
]}

Nguyen, Hannah ^{[2
]}

Dupont, Isabelle ^{[2
]}

Barsalou, Annie ^{[2
]}

Beaulieu, Carole ^{[2
]}

Chute, Ian ^{[2
]}

Gravel, Serge ^{[2
]}

Robert, Marie-France ^{[2
]}

Lefebvre, Sylvain ^{[2
]}

Dubay, Marja ^{[2
]}

Pascal, Roussen ^{[4
]}

Gillespie, Jeff ^{[4
]}

Jin, Zhiyun ^{[4
]}

Wang, James ^{[4
]}

Besterman, Jeffrey M. ^{[2
]}

MacLeod, A. Robert ^{[2
]}

Vaisburg, Arkadii ^{[1
]}

机构：

[1] MethylGene Inc, Dept Med Chem, Montreal, PQ H4S 2A1, Canada

[2] MethylGene Inc, Dept Cell Biol & Pharmacol, Montreal, PQ H4S 2A1, Canada

[3] MethylGene Inc, Dept Lead Discovery, Montreal, PQ H4S 2A1, Canada

[4] MethylGene Inc, Dept PK Analyt Chem, Montreal, PQ H4S 2A1, Canada

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 09期

关键词：

c-Met; VEGFR2; kinase; thieno[3,2-b]pyridine; cancer;

D O I：

10.1016/j.bmcl.2008.04.009

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases is described. The compounds demonstrated potency with IC50 values in the low nanomolar range in vitro while the lead compound also showed in vivo activity against various human tumor xenograft models in mice. Further exploration of this class of compounds is underway. (c) 2008 Elsevier Ltd. All rights reserved.

引用

页码：2793 / 2798

页数：6

共 39 条

[31] Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors
Liu, Mingmei
Hou, Yunlei
Yin, Weile
Zhou, Shunguang
Qian, Ping
Guo, Zhuang
Xu, Liying
Zhao, Yangfang
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 119 : 96 - 108
[32] Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions
Nan, Xiang
Li, Hui-Jing
Fang, Sen-Biao
Li, Qin-Ying
Wu, Yan-Chao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 193
[33] Discovery of Novel Pyrrolo[2,3-b]pyridine-Based CSF-1R Inhibitors with Demonstrated Efficacy against Patient-Derived Colorectal Cancer Organoids
He, Jinting
Gao, Wen
Dong, Rongrong
Lv, Yingshan
Zhang, Qiang
Li, Lin
Xie, Xiaolong
Lv, Qi
Hu, Lihong
Wang, Junwei
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (05) : 5655 - 5674
[34] Synthesis, fluorescence properties of novel thiazolo[3,2-b][1,2,4]triazol derivatives as potent SHP2 inhibitors and its uses in sensing for Fe3+and cell imaging
Yan, Xue
Zhang, Chun
Gao, Li-Xin
Cao, Zi-Tong
Gan, Su-Ya
Li, Jia
Xiang, Da-Jun
Zhou, Yu-Bo
Wang, Wen-Long
JOURNAL OF MOLECULAR STRUCTURE, 2025, 1324
[35] Pyrrolo[3,2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and in Vivo Validation
Unzue, Andrea
Dong, Jing
Lafleur, Karine
Zhao, Hongtao
Frugier, Emilie
Caflisch, Amedeo
Nevado, Cristina
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6834 - 6844
[36] Discovery of novel pyrazole based Urea/Thiourea derivatives as multiple targeting VEGFR-2, EGFRWT, EGFRT790M tyrosine kinases and COX-2 Inhibitors, with anti-cancer and anti-inflammatory activities
Fadaly, Wael A. A.
Nemr, Mohamed T. M.
Kahk, Nesma M.
BIOORGANIC CHEMISTRY, 2024, 147
[37] Discovery of 6-(difluoro(6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b] [1,2,4]triazin-3-yl)methyl)quinoline as a highly potent and selective c-Met inhibitor
Zhan, Zhengsheng
Peng, Xia
Liu, Qiufeng
Chen, Fang
Ji, Yinchun
Yao, Shanyan
Xi, Yong
Lin, Yipeng
Chen, Tiantian
Xu, Yechun
Ai, Jing
Geng, Meiyu
Duan, Wenhu
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 116 : 239 - 251
[38] Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives
Hirose, Masaaki
Okaniwa, Masanori
Miyazaki, Tohru
Imada, Takashi
Ohashi, Tomohiro
Tanaka, Yuta
Arita, Takeo
Yabuki, Masato
Kawamoto, Tomohiro
Tsutsumi, Shunichirou
Sumita, Akihiko
Takagi, Terufumi
Sang, Bi-Ching
Yano, Jason
Aertgeerts, Kathleen
Yoshida, Sei
Ishikawa, Tomoyasu
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (18) : 5600 - 5615
[39] Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization
Zhao, Fei
Zhang, Le-Duo
Hao, Yu
Chen, Na
Bai, Rui
Wang, Yu-Ji
Zhang, Chun-Chun
Li, Gong-Sheng
Hao, Li-Jun
Shi, Chen
Zhang, Jing
Mao, Yu
Fan, Yi
Xia, Guang-Xin
Yu, Jian-Xin
Liu, Yan-Jun
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 134 : 147 - 158

← 1 2 3 4 →